Aligos Therapeutics Gains Fast Track for HBV Drug
SOUTH SAN FRANCISCO, Calif., April 14, 2026 Aligos Therapeutics, Inc. has announced encouraging progress in its Phase 2 B-SUPREME...
Liver Disease
Advertisement
GSK Bepirovirsen Wins EMA Review for Hepatitis B Drug
London, UK | March 27, 2026 EMA Accepts First-in-Class Hepatitis B Therapy for Review GSK has announced that the...
Tangram Advances TGM-312 With Phase 1/2 CTA Submission
LONDON — November 26, 2025. Tangram Therapeutics has submitted a Clinical Trial Application (CTA) to the UK Medicines and...
PDS Biotechnology Presents Strong Immunotherapy and Translational Data Demonstrating Broad Immune Activation at SITC 2025
Princeton, New Jersey, November 10, 2025 — PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company developing next-generation immunotherapies for cancer...
Rivus Pharmaceuticals Reports Positive Phase 2 Results for HU6 in MASH Patients
CHARLOTTESVILLE, Va., and SOUTH SAN FRANCISCO, Calif., November 7, 2025 — Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company pioneering...
Advertisements
Roche Completes Acquisition of 89bio in Strategic Biotech Expansion
Basel, Switzerland – October 30, 2025 — Roche Holding AG (SIX: RO, ROG; OTCQX: RHHBY) has successfully completed its...
Advertisement
